# OneSpan Inc.: financial statements, quarterly

OSPN · Nasdaq · CIK 1044777 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ospn.md) · [Financials](/companies/ospn/financials.md) · [Filings](/companies/ospn/filings.md) · [Insiders](/companies/ospn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ospn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [58.8](/filings/0001628280-24-044353.md) | [62.9](/filings/0001628280-24-009466.md) | [64.8](/filings/0001044777-25-000002.md) | [60.9](/filings/0001044777-25-000017.md) | [56.2](/filings/0001044777-25-000034.md) | [61.2 d](/filings/0001044777-26-000008.md) | [63.4](/filings/0001044777-26-000019.md) | [59.8](/filings/0001044777-26-000040.md) | [57.1](/filings/0001044777-25-000034.md) | [62.9 d](/filings/0001044777-26-000008.md) | [65.9](/filings/0001044777-26-000019.md) | [60.5](/filings/0001044777-26-000040.md) |
| Cost of revenue | $m | [18.2](/filings/0001628280-24-044353.md) | [19.5 d](/filings/0001044777-26-000008.md) | [17.4](/filings/0001044777-25-000002.md) | [20.6](/filings/0001044777-25-000017.md) | [14.7](/filings/0001044777-25-000034.md) | [15.9 d](/filings/0001044777-26-000008.md) | [16.3](/filings/0001044777-26-000019.md) | [15.9](/filings/0001044777-26-000040.md) | [15.1](/filings/0001044777-25-000034.md) | [16.6 d](/filings/0001044777-26-000008.md) | [17.4](/filings/0001044777-26-000019.md) | [16.0](/filings/0001044777-26-000040.md) |
| Gross profit | $m | [40.7](/filings/0001628280-24-044353.md) | [43.5](/filings/0001628280-24-009466.md) | [47.4](/filings/0001044777-25-000002.md) | [40.3](/filings/0001044777-25-000017.md) | [41.5](/filings/0001044777-25-000034.md) | [45.3 d](/filings/0001044777-26-000008.md) | [47.1](/filings/0001044777-26-000019.md) | [44.0](/filings/0001044777-26-000040.md) | [42.0](/filings/0001044777-25-000034.md) | [46.3 d](/filings/0001044777-26-000008.md) | [48.5](/filings/0001044777-26-000019.md) | [44.5](/filings/0001044777-26-000040.md) |
| Research and development | $m | [10.1](/filings/0001628280-24-044353.md) | [8.7 d](/filings/0001044777-26-000008.md) | [8.3](/filings/0001044777-25-000002.md) | [8.3](/filings/0001044777-25-000017.md) | [7.5](/filings/0001044777-25-000034.md) | [8.3 d](/filings/0001044777-26-000008.md) | [7.9](/filings/0001044777-26-000019.md) | [9.4](/filings/0001044777-26-000040.md) | [8.8](/filings/0001044777-25-000034.md) | [8.0 d](/filings/0001044777-26-000008.md) | [9.1](/filings/0001044777-26-000019.md) | [9.9](/filings/0001044777-26-000040.md) |
| Operating income | $m | [(4.8)](/filings/0001628280-24-044353.md) | [1.8](/filings/0001628280-24-009466.md) | [14.1](/filings/0001044777-25-000002.md) | [7.6](/filings/0001044777-25-000017.md) | [11.3](/filings/0001044777-25-000034.md) | [11.8 d](/filings/0001044777-26-000008.md) | [17.2](/filings/0001044777-26-000019.md) | [10.5](/filings/0001044777-26-000040.md) | [8.2](/filings/0001044777-25-000034.md) | [12.5 d](/filings/0001044777-26-000008.md) | [14.8](/filings/0001044777-26-000019.md) | [8.7](/filings/0001044777-26-000040.md) |
| Income tax | $m | [0.3](/filings/0001628280-24-044353.md) | [0.9 d](/filings/0001044777-26-000008.md) | [1.0](/filings/0001044777-25-000002.md) | [1.9](/filings/0001044777-25-000017.md) | [1.7](/filings/0001044777-25-000034.md) | [(15.3) d](/filings/0001044777-26-000008.md) | [3.4](/filings/0001044777-26-000019.md) | [2.2](/filings/0001044777-26-000040.md) | [1.9](/filings/0001044777-25-000034.md) | [(31.0) d](/filings/0001044777-26-000008.md) | [2.8](/filings/0001044777-26-000019.md) | [1.9](/filings/0001044777-26-000040.md) |
| Net income | $m | [(4.1)](/filings/0001628280-24-044353.md) | [0.4](/filings/0001628280-24-009466.md) | [13.5](/filings/0001044777-25-000034.md) | [6.6](/filings/0001044777-25-000034.md) | [8.3](/filings/0001044777-25-000034.md) | [28.8 d](/filings/0001044777-26-000008.md) | [14.5](/filings/0001044777-26-000040.md) | [8.3](/filings/0001044777-26-000040.md) | [6.5](/filings/0001044777-25-000034.md) | [43.5 d](/filings/0001044777-26-000008.md) | [11.6](/filings/0001044777-26-000040.md) | [6.8](/filings/0001044777-26-000040.md) |
| Diluted EPS | $ per share | [(0.10)](/filings/0001628280-24-044353.md) | [0.01](/filings/0001628280-24-009466.md) | [0.35](/filings/0001044777-25-000002.md) | [0.17](/filings/0001044777-25-000017.md) | [0.21](/filings/0001044777-25-000034.md) | not reported | [0.37](/filings/0001044777-26-000019.md) | [0.21](/filings/0001044777-26-000040.md) | [0.17](/filings/0001044777-25-000034.md) | not reported | [0.30](/filings/0001044777-26-000019.md) | [0.18](/filings/0001044777-26-000040.md) |
| Basic EPS | $ per share | [(0.10)](/filings/0001628280-24-044353.md) | [0.01](/filings/0001628280-24-009466.md) | [0.35](/filings/0001044777-25-000002.md) | [0.17](/filings/0001044777-25-000017.md) | [0.21](/filings/0001044777-25-000034.md) | not reported | [0.38](/filings/0001044777-26-000019.md) | [0.22](/filings/0001044777-26-000040.md) | [0.17](/filings/0001044777-25-000034.md) | not reported | [0.31](/filings/0001044777-26-000019.md) | [0.18](/filings/0001044777-26-000040.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [68.5](/filings/0001628280-23-037934.md) | [43.0](/filings/0001628280-25-008750.md) | [63.9](/filings/0001628280-24-020067.md) | [63.8](/filings/0001628280-24-034222.md) | [77.5](/filings/0001628280-24-044353.md) | [83.2](/filings/0001044777-26-000008.md) | [105](/filings/0001044777-25-000002.md) | [92.9](/filings/0001044777-25-000017.md) | [85.6](/filings/0001044777-25-000034.md) | [70.5](/filings/0001044777-26-000040.md) | [49.8](/filings/0001044777-26-000019.md) | [43.3](/filings/0001044777-26-000040.md) |
| Current assets | $m | [146](/filings/0001628280-23-037934.md) | [146](/filings/0001628280-25-008750.md) | [134](/filings/0001628280-24-020067.md) | [144](/filings/0001628280-24-034222.md) | [142](/filings/0001628280-24-044353.md) | [175](/filings/0001044777-26-000008.md) | [171](/filings/0001044777-25-000002.md) | [169](/filings/0001044777-25-000017.md) | [158](/filings/0001044777-25-000034.md) | [172](/filings/0001044777-26-000040.md) | [123](/filings/0001044777-26-000019.md) | [128](/filings/0001044777-26-000040.md) |
| Total assets | $m | [283](/filings/0001628280-23-037934.md) | [289](/filings/0001628280-25-008750.md) | [277](/filings/0001628280-24-020067.md) | [287](/filings/0001628280-24-034222.md) | [289](/filings/0001628280-24-044353.md) | [339](/filings/0001044777-26-000008.md) | [334](/filings/0001044777-25-000002.md) | [357](/filings/0001044777-25-000017.md) | [344](/filings/0001044777-25-000034.md) | [398](/filings/0001044777-26-000040.md) | [383](/filings/0001044777-26-000019.md) | [387](/filings/0001044777-26-000040.md) |
| Current liabilities | $m | [91.3](/filings/0001628280-23-037934.md) | [115](/filings/0001628280-25-008750.md) | [92.2](/filings/0001628280-24-020067.md) | [93.7](/filings/0001628280-24-034222.md) | [80.4](/filings/0001628280-24-044353.md) | [110](/filings/0001044777-26-000008.md) | [87.0](/filings/0001044777-25-000002.md) | [95.6](/filings/0001044777-25-000017.md) | [90.0](/filings/0001044777-25-000034.md) | [115](/filings/0001044777-26-000040.md) | [98.0](/filings/0001044777-26-000019.md) | [96.2](/filings/0001044777-26-000040.md) |
| Total liabilities | $m | [105](/filings/0001628280-23-037934.md) | [130](/filings/0001628280-25-008750.md) | [106](/filings/0001628280-24-020067.md) | [108](/filings/0001628280-24-034222.md) | [94.7](/filings/0001628280-24-044353.md) | [126](/filings/0001044777-26-000008.md) | [103](/filings/0001044777-25-000002.md) | [115](/filings/0001044777-25-000017.md) | [105](/filings/0001044777-25-000034.md) | [126](/filings/0001044777-26-000040.md) | [111](/filings/0001044777-26-000019.md) | [114](/filings/0001044777-26-000040.md) |
| Shareholders' equity | $m | [177](/filings/0001628280-24-044353.md) | [159](/filings/0001044777-26-000008.md) | [171](/filings/0001044777-25-000034.md) | [179](/filings/0001044777-25-000034.md) | [195](/filings/0001044777-25-000034.md) | [213](/filings/0001044777-26-000040.md) | [231](/filings/0001044777-26-000040.md) | [243](/filings/0001044777-26-000040.md) | [238](/filings/0001044777-25-000034.md) | [272](/filings/0001044777-26-000040.md) | [272](/filings/0001044777-26-000040.md) | [273](/filings/0001044777-26-000040.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(7.4) d](/filings/0001628280-24-044353.md) | [3.1 d](/filings/0001044777-26-000008.md) | [27.0](/filings/0001044777-25-000002.md) | [2.3 d](/filings/0001044777-25-000017.md) | [14.0 d](/filings/0001044777-25-000034.md) | [12.4 d](/filings/0001044777-26-000008.md) | [29.4](/filings/0001044777-26-000019.md) | [6.2 d](/filings/0001044777-26-000040.md) | [11.3 d](/filings/0001044777-25-000034.md) | [12.6 d](/filings/0001044777-26-000008.md) | [28.2](/filings/0001044777-26-000019.md) | [(0.1) d](/filings/0001044777-26-000040.md) |
| Capital expenditure | $m | [2.5 d](/filings/0001628280-24-044353.md) | [3.4 d](/filings/0001044777-26-000008.md) | [3.0](/filings/0001044777-25-000002.md) | [2.3 d](/filings/0001044777-25-000017.md) | [2.0 d](/filings/0001044777-25-000034.md) | [2.0 d](/filings/0001044777-26-000008.md) | [1.6](/filings/0001044777-26-000019.md) | [1.9 d](/filings/0001044777-26-000040.md) | [2.5 d](/filings/0001044777-25-000034.md) | [2.9 d](/filings/0001044777-26-000008.md) | [3.1](/filings/0001044777-26-000019.md) | [3.2 d](/filings/0001044777-26-000040.md) |
| Dividends paid | $m | not reported | not reported | [0.0](/filings/0001044777-25-000002.md) | [0.0 d](/filings/0001044777-25-000017.md) | [0.0 d](/filings/0001044777-25-000034.md) | [0.0 d](/filings/0001044777-26-000008.md) | [4.6](/filings/0001044777-26-000019.md) | [4.6 d](/filings/0001044777-26-000040.md) | [4.7 d](/filings/0001044777-25-000034.md) | [4.6 d](/filings/0001044777-26-000008.md) | [5.0](/filings/0001044777-26-000019.md) | [4.8 d](/filings/0001044777-26-000040.md) |
| Share repurchases | $m | [3.5 d](/filings/0001628280-24-044353.md) | [25.6 d](/filings/0001044777-26-000008.md) | not reported | not reported | not reported | [0.0 d](/filings/0001044777-26-000008.md) | [0.0](/filings/0001044777-26-000019.md) | [0.0 d](/filings/0001044777-26-000040.md) | [6.3 d](/filings/0001044777-25-000034.md) | [6.8 d](/filings/0001044777-26-000008.md) | [5.4](/filings/0001044777-26-000019.md) | [2.9 d](/filings/0001044777-26-000040.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [39.7](/filings/0001628280-23-037934.md) | [40.1](/filings/0001628280-24-020067.md) | [40.4](/filings/0001628280-24-034222.md) | [40.5](/filings/0001628280-24-044353.md) | [38.5](/filings/0001044777-25-000002.md) | [39.0](/filings/0001044777-25-000017.md) | [39.5](/filings/0001044777-25-000034.md) | [39.0](/filings/0001044777-26-000019.md) | [39.0](/filings/0001044777-26-000040.md) | [38.8](/filings/0001044777-25-000034.md) | [38.1](/filings/0001044777-26-000019.md) | [38.1](/filings/0001044777-26-000040.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 36,852,173 at 2026-07-30, from the cover of the [10-Q filed 2026-08-04](/filings/0001044777-26-000040.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.